LISTED medical life sciences firm Medlab Clinical has announced a new agreement with Australian Pharmaceutical Industries (API), which will stock Medlab's core nutraceutical range across its Priceline Pharmacy network.
The wide-ranging deal will make the products available through over 475 stores including 350 pharmacies, while API will also wholesale the range meaning more than 2,100 independent pharmacies will also be able to access the nutraceuticals.
"The agreement positions Medlab's nutraceutical range into professional pharmacy, with onboarding expected to take 3-4 months," said Medlab CEO Dr Sean Hall, adding that it was anticipated that the deal would result in a "substantial increase in sales".
The Medlab range is distinguished by its exposure to clinical research, with the company currently holding 27 patents covering a significant number of the nutraceutical products which include NanoCelle items delivered using Medlab's patented delivery platform.
"Medlab is very excited with this opportunity to work with Priceline Pharmacy and other independent groups, as it allows us to support people in the community suffering chronic illnesses by providing them easier access to scientifically backed products," Hall said.
Medlab has also announced it expects to exhibit at this years APP conference on the Gold Coast, taking place in just over a month.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Jan 19
